Hjem › Leukæmi › Pennsylvania › Philadelphia
Leukæmi kliniske forsøg i Philadelphia, PA
12 studier for Leukæmi søger deltagere på steder i og omkring Philadelphia (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservationsstudie
- Children's Hospital of Philadelphia, Philadelphia
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekruttererFase 1/2
- University of Pennsylvania, Philadelphia
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
RekruttererFase 1
- Children's Hospital of Philadelphia, Philadelphia
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekruttererFase 3
- University of Pennsylvania, Philadelphia
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RekruttererFase 2
- Children's Hospital of Philadelphia, Philadelphia
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies
RekruttererObservationsstudie
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Children's Hospital of Philadelphia, Philadelphia
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekruttererObservationsstudie
- Saint Christopher's Hospital for Children, Philadelphia
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
RekruttererFase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- Hospital of the University of Pennsylvania, Philadelphia
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
RekruttererTidlig fase 1
- Children's Hospital of Philadelphia, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservationsstudie
- Massive Bio SYNERGY-AI site, Philadelphia
Leukæmi forsøg i andre byer
- Houston, TX28 studier
- Boston, MA25 studier
- New York City, NY19 studier
- Los Angeles, CA16 studier
- Chicago, IL16 studier
- Durham, NC13 studier
- Baldwin Park, CA12 studier
- Columbus, OH12 studier
- Nashville, TN12 studier
- Milwaukee, WI11 studier
- Atlanta, GA11 studier
- Seattle, WA11 studier
Andre studier i Philadelphia
- Kræft (alle typer)59 studier
- Brystkræft56 studier
- Ikke-småcellet lungecancer51 studier
- Metastatisk cancer46 studier
- Colorektal kræft44 studier
- Ægstockræft44 studier
- Prostatakræft44 studier
- Lungecancer36 studier
- Akut myeloid leukæmi34 studier
- Hjertesvigt31 studier
- Livmoderslimhindekræft28 studier
- Depression26 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.